Harvest Fund Management Co., LTD Penumbra Inc Transaction History

Harvest Fund Management Co., LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 07, 2023	BUY	$271.54 - $344.06 $91,780 - $116,292	338 Added 40.24%	1,178 $405,000
Q1 2023 May 10, 2023	BUY	$220.43 - $278.69 $165,102 - $208,738	749 Added 823.08%	840 $234,000
Q4 2022 Feb 06, 2023	SELL	$151.88 - $228.5 $49,361 - $74,262	-325 Reduced 78.13%	91 $20,000
Q3 2022 Nov 10, 2022	BUY	$120.36 - $205.88 $32,858 - $56,205	273 Added 190.91%	416 $79,000
Q1 2022 May 12, 2022	SELL	$187.51 - $283.98 $39,564 - $59,919	-211 Reduced 59.6%	143 $31,000
Q3 2021 Nov 15, 2021	BUY	$250.72 - $291.24 $46,884 - $54,461	187 Added 111.98%	354 $94,000
Q2 2021 Aug 11, 2021	BUY	$235.0 - $310.7 $25,145 - $33,244	107 Added 178.33%	167 $46,000
Q1 2021 May 13, 2021	BUY	$175.6 - $291.43 $10,536 - $17,485	60 New	60 $16,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.09B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.